Elliot Norry, M.D.
Chief Medical Officer
@
Adaptimmune
About Elliot Norry, M.D.
Elliot Norry, M.D., is a seasoned medical professional with extensive experience in internal medicine and gastroenterology, currently serving as the Chief Medical Officer.
Known information
Elliot Norry, M.D., holds a B.A. from Columbia College and an M.D. from New York University. He completed his residency in Internal Medicine at Temple University Hospital in Philadelphia, followed by a fellowship in gastroenterology at Thomas Jefferson University Hospital. Dr. Norry practiced adult internal medicine at Abington Memorial Hospital in Pennsylvania for 13 years. He later joined GSK, where he served as Safety Development Leader from 2009, managing clinical safety for various products, including pazopanib for soft tissue sarcoma. Additionally, he was the Chair of GSK’s Hepatic Safety Panel, overseeing liver safety concerns across the company’s product range.
About Adaptimmune
Adaptimmune is a biotechnology company specializing in the development of T-cell-based therapies for cancer treatment, with a focus on engineering patients' own cells to combat solid tumors.